info@projectsinindia.com
Thane, Maharashtra Get Free Demo →
InsightsData report
Data report · Drugs & Pharmaceuticals

Drugs & Pharmaceuticals Plant Projects in India 2026

Projects India tracks 1,425 upcoming drugs and pharmaceuticals projects across India, with a combined recorded cost of about Rs 92,327 crore. Gujarat leads with 462 projects, followed by Telangana and Andhra Pradesh.

NS
Nitisha ShindeResearch Desk, Projects India

9 min read · 1,747 words
Drugs & Pharmaceuticals Plant Projects in India 2026

Projects India tracks 1,425 upcoming drugs and pharmaceuticals projects across India — of which 1,138 are verified — with a combined recorded cost of about Rs 92,327 crore. Fourteen new projects were added to our database in the last 90 days, making this one of the more active industrial segments we cover. For EPC contractors, process equipment suppliers and B2B sales teams, the pipeline is substantial and spread across multiple states.

Pharma and biotech plant projects in India: at a glance

MetricFigure
Upcoming projects tracked1,425
Verified projects1,138
Combined recorded project costAbout Rs 92,327 crore
New projects added (last 90 days)14
New projects added (prior 90 days)19
Top state by project countGujarat (462 projects)
Projects under construction363
Projects under approvals637

Largest upcoming pharma and biotech plant projects in India

The table below lists the highest-value upcoming investments our database records in this scope. Several are in active construction while others are still clearing regulatory approvals — both stages represent distinct commercial windows for suppliers and contractors.

ProjectPromoterLocationCostStage
Bulk Drug and Formulation Pharma Park Plant ProjectBhaderiya PharmaLalitpur, Uttar PradeshRs 12,000 croreApprovals Received
Health & Wellness Products Unit ProjectProcter & Gamble Hygiene & Health Care LimitedAhmedabad, GujaratRs 2,000 croreHold
Active Pharmaceutical Ingredients ProjectGranules India LimitedKakinada, Andhra PradeshRs 2,000 croreHold
API Project [Unit IV]Anthem BiosciencesBengaluru, KarnatakaRs 1,300 croreApprovals Received
Ayurvedic & Allopathy Medicines Mfg Unit ProjectHNE Healthcare Private LimitedSolan, Himachal PradeshRs 1,283 croreUnder Approvals
Bulk Drug Mfg Unit ProjectAndhra Pradesh Bulk Drug Infrastructure Corporation LimitedVisakhapatnam, Andhra PradeshRs 1,257 croreConstruction Started
Bulk Drugs & Drug Intermediates Mfg Unit ProjectVirupaksha Organics LimitedKurnool, Andhra PradeshRs 1,225 crorePlanning
Biologicals Antibodies ProjectBiocon Biologics India LimitedBengaluru, KarnatakaRs 1,060 croreUnder Approvals
Bulk Drugs Mfg Unit ProjectTorrent Pharmaceuticals LimitedGandhinagar, GujaratRs 1,000 croreConstruction Started
Capsules ProjectGlaxoSmithkline Pharmaceuticals LimitedKolar, KarnatakaRs 1,000 croreConstruction Started
Vaccines ProjectSerum Institute of India LimitedPune, MaharashtraRs 1,000 croreConstruction Started
Vaccines ProjectHLL Biotech LimitedChennai, Tamil NaduRs 890 croreConstruction Started
API Mfg Unit Project – ExpansionSynthimed Labs Private LimitedSAS Nagar, PunjabRs 856 croreUnder Approvals
Pharmaceutical Mfg and Injectables Fill Unit ProjectJags Pharma Private LimitedNalagarh, Himachal PradeshRs 750 croreUnder Approvals
Bulk Drugs and Intermediates ProjectDivi's Laboratories LimitedEast Godavari, Andhra PradeshRs 750 crorePlanning

The Bhaderiya Pharma pharma park in Lalitpur at Rs 12,000 crore stands apart in scale from the rest of the list, with approvals already received — signalling that procurement and EPC engagement could begin relatively soon. Six of the fifteen projects are already in construction, meaning civil, mechanical and utility contractors are actively needed at those sites. The concentration of bulk drug and API investments in Andhra Pradesh underscores the state's push to position itself as a bulk drug hub alongside the more established Gujarat cluster. For more on the Gujarat pipeline, see our dedicated piece on upcoming pharma projects in Gujarat.

Where the projects are: state-by-state distribution

Gujarat dominates the national pipeline by a wide margin, as the chart below shows.

Upcoming projects by state — Drugs & Pharmaceuticals in India
Upcoming projects by state — Drugs & Pharmaceuticals in India — Gujarat: 462; Telangana: 195; Andhra Pradesh: 194; Karnataka: 184; Maharashtra: 136; Himachal Pradesh: 50; Madhya Pradesh: 48; Uttarakhand: 32; Tamil Nadu: 24; Rajasthan: 22Gujarat462Telangana195Andhra Pradesh194Karnataka184Maharashtra136Himachal Pradesh50Madhya Pradesh48Uttarakhand32Tamil Nadu24Rajasthan22
Source: Projects India database, October 2026

Gujarat's 462 projects reflect decades of chemical and pharmaceutical cluster development around Ahmedabad, Ankleshwar, Bharuch and Vadodara. For process equipment suppliers — reactors, columns, heat exchangers, filtration systems — the state offers the densest concentration of potential buyers in India. Telangana (195 projects) and Andhra Pradesh (194 projects) together form a significant southern corridor, with Hyderabad's pharma belt feeding Telangana's count and the Andhra Pradesh Bulk Drug Park driving new investment in the Visakhapatnam and Kurnool districts. Karnataka (184 projects) is notable for high-value biologics and API investments, particularly around Bengaluru. Himachal Pradesh (50 projects) and Uttarakhand (32 projects) continue to attract formulations manufacturing on account of fiscal incentives. For the Telangana picture in detail, our article on upcoming pharma projects in Hyderabad and Telangana covers the pipeline there.

What stage are these projects at — and what does that mean for vendors

Stage distribution across all projects in this scope — including completed and cancelled ones — reveals where the active commercial opportunity sits, as the chart below shows.

Projects by stage — Drugs & Pharmaceuticals in India
Projects by stage — Drugs & Pharmaceuticals in India — Under Approvals: 637; Construction Started: 363; Completed: 323; Hold: 138; Approvals Received: 137; Planning: 98; Nearly Completion: 52; Cancelled: 48Under Approvals637Construction Started363Completed323Hold138Approvals Received137Planning98Nearly Completion52Cancelled48
Source: Projects India database, October 2026

With 637 projects under approvals and a further 137 with approvals received, the pre-construction segment is the largest single block. These projects are actively seeking CPCB, factory inspectorate and industrial area authority clearances; vendors who engage decision-makers at this stage — with product data, utility layouts and compliance documentation — are best placed to be specified in the project design. The 363 projects in construction represent live demand for equipment, civil contractors, piping fabricators and electrical and instrumentation suppliers. Projects at the planning stage (98 in count) are early but worth monitoring; they represent the next wave to enter approvals. The 138 projects on hold are not dead — they can reactivate when financing or regulatory conditions shift — but they should be watched rather than actively chased. A full breakdown of EPC and construction contractors serving this sector is available in our related article on pharma EPC and construction contractors in India.

Projects added to our database in the last 90 days

Fourteen projects were added to the Projects India database in the most recent 90-day window, compared with 19 in the 90 days before that. The recent additions skew toward smaller greenfield and expansion investments, most in the Under Approvals or early construction stage. Key additions include:

Palghar in Maharashtra appears twice in the recent additions — Aarti Pharmalabs' expansion and Aadi Rishabh Chemicals' new unit. Ankleshwar in Gujarat also appears twice, consistent with the state's overall dominance. Suppliers of pharmaceutical-grade process equipment, utility systems and laboratory fitouts who are not already monitoring these clusters should note that both areas have active planning pipelines. Our directory entry for S V Labs Private Limited is one example of a company profile available in our contractor and supplier directory.

Most active promoters in this segment

Repeat investors tend to buy equipment and services in volume across multiple projects, making them priority targets for supplier business development teams, as the chart below shows.

Most active promoters — Drugs & Pharmaceuticals in India (projects)
Most active promoters — Drugs & Pharmaceuticals in India (projects) — Divi's Laboratories Limited: 8; Biocon Biologics India Limited: 6; Aurobindo Pharma Limited: 6; Bio Vin Research Laboratories Private Limited: 5; GlaxoSmithkline Pharmaceuticals Limited: 4; Torrent Pharmaceuticals Limited: 4; Inventys Research Company Private Limited: 4; Glenmark Life Sciences Limited: 4; Optimus Drugs Private Limited: 4; Mankind Pharma Limited: 4Divi's Laboratories Limited8Biocon Biologics India Limited6Aurobindo Pharma Limited6Bio Vin Research Laboratories Pri…5GlaxoSmithkline Pharmaceuticals L…4Torrent Pharmaceuticals Limited4Inventys Research Company Private…4Glenmark Life Sciences Limited4Optimus Drugs Private Limited4Mankind Pharma Limited4
Source: Projects India database, October 2026

Divi's Laboratories Limited leads with eight projects and a combined recorded cost of about Rs 2,800 crore. Biocon Biologics India Limited follows with six projects worth about Rs 2,264 crore, largely in biologics and antibody manufacturing. GlaxoSmithkline Pharmaceuticals Limited's four projects carry a combined recorded cost of about Rs 3,000 crore — the highest per-project average among the top promoters — reflecting the capital intensity of formulations and capsule manufacturing at scale. Torrent Pharmaceuticals, Inventys Research Company and Glenmark Life Sciences each have four projects, spanning API and intermediates production. For suppliers, a relationship with any of these promoters' procurement teams can open access to recurring work across multiple sites over an extended period.

What this means for suppliers and contractors

The stage and geography of this pipeline translate into specific procurement windows that vendors can act on now:

Process equipment suppliers targeting Gujarat specifically will find the highest density of concurrent opportunities; those with capacity to serve both large pharma parks and smaller greenfield units in clusters like Ankleshwar, Bharuch and Gandhinagar can build a strong regional order book. For a broader view of live government tenders in the sector, see our live tenders section.

How to track these projects

The 1,425 projects in this scope — and the 84,726 projects Projects India tracks nationally — are updated on a continuing basis as promoters file approvals, break ground or award contracts. The most practical way for an EPC contractor or equipment supplier to use this intelligence is to filter by state, stage and project type, then set alerts for when a project moves from approvals into construction. Our drugs and pharmaceuticals project database allows exactly this kind of filtered access, and the projects intelligence section explains how the data is structured and verified. Teams evaluating the platform before committing can request a free sample project report to see the depth of decision-maker contact and tender-status information available. For companies in the contractor and supplier ecosystem looking to be found by promoters, the VendorConnect directory lists firms by capability and geography across all industrial segments covered in our database.

Frequently asked questions

What is Endoc Biotech Pvt Ltd and are there related pharma plant projects in India?

Endoc Biotech Pvt Ltd is one of several emerging biotech and pharma companies appearing in project searches. Projects India tracks 1,425 upcoming drugs and pharmaceuticals projects nationally, including greenfield and expansion investments at similar-scale promoters. Decision-maker contacts and approval status are recorded for verified projects in our database.

How many pharma and biotech plant projects are currently active in Gujarat?

Gujarat has 462 drugs and pharmaceuticals projects in the Projects India database — more than any other state. Key clusters include Ankleshwar, Bharuch, Ahmedabad, Gandhinagar and Vadodara. Recent additions include new and expansion investments by Valeshvar Biotech and VB Genetics, both in Ankleshwar.

What is the combined investment value of upcoming pharma projects in India?

Projects India records a combined cost of about Rs 92,327 crore across upcoming drugs and pharmaceuticals projects in India that have a recorded cost. The largest single project is Bhaderiya Pharma's bulk drug and formulation pharma park in Lalitpur, Uttar Pradesh, valued at Rs 12,000 crore.

Which companies have the most pharma plant projects underway in India?

Among promoters tracked by Projects India, Divi's Laboratories leads with eight projects worth about Rs 2,800 crore. Biocon Biologics India has six projects worth about Rs 2,264 crore, and GlaxoSmithkline Pharmaceuticals has four projects with a combined recorded cost of about Rs 3,000 crore.

What process equipment is in demand for pharma plant projects currently under construction?

Projects in the construction-started stage — 363 in this scope — are actively procuring reactors, distillation columns, solvent recovery systems, HVAC and clean utilities, piping, instrumentation, insulation and validation services. High-value active sites include the Torrent Pharmaceuticals unit in Gandhinagar and the Andhra Pradesh Bulk Drug Infrastructure Corporation project in Visakhapatnam.

Where can I find details on S V Labs Private Limited or similar pharma companies in India?

Projects India maintains a contractor and supplier directory that includes company profiles such as S V Labs Private Limited. The directory covers firms by capability, geography and sector across the industrial projects database. EPC contractors and equipment suppliers can also list their own firms to be found by project promoters.

Get the full list of 1,811 Drugs & Pharmaceuticals projects in India

  • Project name, promoter, cost, stage and location
  • Verified decision-maker contacts
  • Updated daily — plus live tenders
Or ask on WhatsApp Browse Drugs & Pharmaceuticals projects in India →
NS
About the authorNitisha Shinde · Research Desk, Projects India

Nitisha Shinde leads the research desk at Projects India, which tracks upcoming private and government projects, tenders and awarded contracts across 51 sectors in India.

This article was drafted with AI assistance from Projects India's own project and tender records, and checked against those records before publication.

More from Insights

Upcoming Pharma Projects in Maharashtra: Key Leads
Upcoming Pharma Projects in Maharashtra: Key Leads
Upcoming Pharma Projects in Hyderabad & Telangana
Upcoming Pharma Projects in Hyderabad & Telangana
Upcoming Pharma Projects in Gujarat: Key Plant Leads
Upcoming Pharma Projects in Gujarat: Key Plant Leads